BR9711366A - Uso de inibidores pkc para a fabrica-Æo de um medicamento para o tratamento de infec-{es por htvl-1 - Google Patents
Uso de inibidores pkc para a fabrica-Æo de um medicamento para o tratamento de infec-{es por htvl-1Info
- Publication number
- BR9711366A BR9711366A BR9711366A BR9711366A BR9711366A BR 9711366 A BR9711366 A BR 9711366A BR 9711366 A BR9711366 A BR 9711366A BR 9711366 A BR9711366 A BR 9711366A BR 9711366 A BR9711366 A BR 9711366A
- Authority
- BR
- Brazil
- Prior art keywords
- htvl
- infections
- drug
- manufacture
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2493896P | 1996-08-30 | 1996-08-30 | |
| US08/917,517 US5962446A (en) | 1996-08-30 | 1997-08-26 | Therapetutic treatment for human T cell lymphotrophic virus type 1 infection |
| PCT/US1997/015524 WO1998008508A1 (en) | 1996-08-30 | 1997-08-28 | Use of pkc inhibitors for the manufacture of a medicament for the treatment of htlv-1 infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9711366A true BR9711366A (pt) | 1999-08-17 |
Family
ID=26699066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9711366A BR9711366A (pt) | 1996-08-30 | 1997-08-28 | Uso de inibidores pkc para a fabrica-Æo de um medicamento para o tratamento de infec-{es por htvl-1 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5962446A (pt) |
| EP (1) | EP0830861A1 (pt) |
| JP (1) | JP2002514176A (pt) |
| KR (1) | KR20000035864A (pt) |
| CN (1) | CN1231608A (pt) |
| AU (1) | AU4179397A (pt) |
| BR (1) | BR9711366A (pt) |
| CA (1) | CA2263161A1 (pt) |
| EA (1) | EA199900243A1 (pt) |
| IL (1) | IL128493A0 (pt) |
| NO (1) | NO990948L (pt) |
| PL (1) | PL331759A1 (pt) |
| TR (1) | TR199900905T2 (pt) |
| WO (1) | WO1998008508A1 (pt) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK278989B6 (sk) * | 1988-02-10 | 1998-05-06 | F. Hoffmann-La Roche Ag | Substituované pyroly, ich použitie na výrobu lieči |
| US5380746A (en) * | 1989-05-05 | 1995-01-10 | Goedecke Aktiengesellschaft | Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| US5063238A (en) * | 1989-11-13 | 1991-11-05 | Merrell Dow Pharmaceuticals Inc. | Prevention of glycoprotein enveloped virus infectivity by pyridinyloxazole-2-ones |
| DE4243321A1 (de) * | 1992-12-21 | 1994-06-23 | Goedecke Ag | Aminosäurederivate von Heterocyclen als PKC-Inhibitoren |
| US5624949A (en) * | 1993-12-07 | 1997-04-29 | Eli Lilly And Company | Protein kinase C inhibitors |
| HU219709B (hu) * | 1993-12-07 | 2001-06-28 | Eli Lilly And Co. | Proteinkináz C gátló hatású kondenzált indolszármazékok, eljárás előállításukra, és az ezeket tartalmazó gyógyászati készítmények |
| DK0657411T3 (da) * | 1993-12-07 | 1999-11-15 | Lilly Co Eli | Forbedret syntese af bisindolylmaleimider |
| US5545636A (en) * | 1993-12-23 | 1996-08-13 | Eli Lilly And Company | Protein kinase C inhibitors |
| US5491242A (en) * | 1994-06-22 | 1996-02-13 | Eli Lilly And Company | Protein kinase C inhibitors |
| US5481003A (en) * | 1994-06-22 | 1996-01-02 | Eli Lilly And Company | Protein kinase C inhibitors |
-
1997
- 1997-08-26 US US08/917,517 patent/US5962446A/en not_active Expired - Fee Related
- 1997-08-28 EA EA199900243A patent/EA199900243A1/ru unknown
- 1997-08-28 BR BR9711366A patent/BR9711366A/pt not_active Application Discontinuation
- 1997-08-28 JP JP51201098A patent/JP2002514176A/ja active Pending
- 1997-08-28 IL IL12849397A patent/IL128493A0/xx unknown
- 1997-08-28 KR KR1019997001559A patent/KR20000035864A/ko not_active Application Discontinuation
- 1997-08-28 AU AU41793/97A patent/AU4179397A/en not_active Abandoned
- 1997-08-28 CN CN97198160A patent/CN1231608A/zh active Pending
- 1997-08-28 CA CA002263161A patent/CA2263161A1/en not_active Abandoned
- 1997-08-28 WO PCT/US1997/015524 patent/WO1998008508A1/en not_active Application Discontinuation
- 1997-08-28 TR TR1999/00905T patent/TR199900905T2/xx unknown
- 1997-08-28 PL PL97331759A patent/PL331759A1/xx unknown
- 1997-09-01 EP EP97306715A patent/EP0830861A1/en not_active Withdrawn
-
1999
- 1999-02-26 NO NO990948A patent/NO990948L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1231608A (zh) | 1999-10-13 |
| US5962446A (en) | 1999-10-05 |
| EP0830861A1 (en) | 1998-03-25 |
| NO990948D0 (no) | 1999-02-26 |
| NO990948L (no) | 1999-04-28 |
| PL331759A1 (en) | 1999-08-02 |
| WO1998008508A1 (en) | 1998-03-05 |
| JP2002514176A (ja) | 2002-05-14 |
| EA199900243A1 (ru) | 1999-10-28 |
| KR20000035864A (ko) | 2000-06-26 |
| AU4179397A (en) | 1998-03-19 |
| CA2263161A1 (en) | 1998-03-05 |
| IL128493A0 (en) | 2000-01-31 |
| TR199900905T2 (xx) | 1999-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT977748E (pt) | Derivados benzopirano substituidos para o tratamento de inflamacao | |
| PT1147083E (pt) | Derivados de arilpiperazinil-ciclohexilindole para o tratamento da depressao | |
| PT956858E (pt) | Composicoes farmaceuticas contendo lactobacilos para o tratamento de infeccoes vaginais | |
| PT998272E (pt) | Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol | |
| PT812195E (pt) | Composicao farmaceutica para compostos de piperidinoalcanol | |
| BR9701673A (pt) | Disposição para a aplicação de um líquido medicinal | |
| PT1162969E (pt) | Utilizacao de inibidores da dipeptidilpeptidase iv para a melhoria da fertilidade | |
| PT862915E (pt) | Composicao antibacteriana para administracao oral | |
| PT1206436E (pt) | Retinoides para o tratamento de enfisema | |
| BR9610733A (pt) | Composto processos para a preparação do mesmo e para o tratamento de um mamífero composição farmacêutica e utilização de um composto | |
| BR9711008A (pt) | Derivados de multilina de carbamoilÄxi azabicicliocos para uso antibacteriano | |
| PT777457E (pt) | A utilizacao de triacetato de glicerilo para o tratamento de onicomicoses | |
| PT970266E (pt) | Dispositivo para o tratamento de superficies por imersao | |
| BR9806083A (pt) | Composi-Æo farmac-utica para o tratamento da hapattite c | |
| PT808877E (pt) | Massa destinada para o revestimento de chapas | |
| PT1220858E (pt) | Oxazinoquinolonas uteis para o tratamento de infeccoes virais | |
| PT866699E (pt) | Utilizacao de inibidores de colinesterase para o fabrico de um medicamento para o tratamento de xerostomia | |
| BR9711329A (pt) | Utiliza-Æo de inibidores pkc para a fabrica-Æo de medicamento para tratamento da aids | |
| PT1086682E (pt) | Utilizacao de derivados de arilo(ou heteroaril)azolil-carbinol na preparacao de um medicamento para o tratamento de inflamacao neurogenica | |
| CL2004001291A1 (es) | Composicion farmaceutica que comprende compuestos carbociclicos y heterociclicos; y su uso para el tratamiento o profilaxis de la infeccion por influenza. | |
| BR9711366A (pt) | Uso de inibidores pkc para a fabrica-Æo de um medicamento para o tratamento de infec-{es por htvl-1 | |
| PT1200447E (pt) | Oxazinocarbazoles para o tratamento de doencas do snc | |
| PT970080E (pt) | Derivados de imino-aza-antraciclinona para o tartamento de amiloidoses | |
| BR9507732A (pt) | Composição farmacêutica para o tratamento de glaucoma | |
| PT804199E (pt) | Uso de penciclovir para o tratamento de nevralgias pos-herpeticas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |